Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Acid ceramidase inhibition ameliorates α-synuclein accumulation upon loss of GBA1 function
Myung Jong Kim, Sohee Jeon, Lena F. Burbulla, et al.
Human Molecular Genetics (2018) Vol. 27, Iss. 11, pp. 1972-1988
Open Access | Times Cited: 66

Showing 26-50 of 66 citing articles:

Emerging links between pediatric lysosomal storage diseases and adult parkinsonism
Daniel Ysselstein, Joshua Shulman, Dimitri Krainc
Movement Disorders (2019) Vol. 34, Iss. 5, pp. 614-624
Open Access | Times Cited: 40
Lysosomal Ceramide Metabolism Disorders: Implications in Parkinson’s Disease
Silvia Paciotti, Elisabetta Albi, Lucilla Parnetti, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 2, pp. 594-594
Open Access | Times Cited: 39
The Link between Gaucher Disease and Parkinson’s Disease Sheds Light on Old and Novel Disorders of Sphingolipid Metabolism
Rossella Indellicato, Marco Trinchera
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 13, pp. 3304-3304
Open Access | Times Cited: 36
Organoid and pluripotent stem cells in Parkinson’s disease modeling: an expert view on their value to drug discovery
Nicolas Marotta, Soojin Kim, Dimitri Krainc
Expert Opinion on Drug Discovery (2020) Vol. 15, Iss. 4, pp. 427-441
Open Access | Times Cited: 33
Lipidomics Prediction of Parkinson’s Disease Severity: A Machine-Learning Analysis
Hila Avisar, Cristina Guardia‐Laguarta, Estela Área-Gómez, et al.
Journal of Parkinson s Disease (2021) Vol. 11, Iss. 3, pp. 1141-1155
Open Access | Times Cited: 29
iPSCs: A Preclinical Drug Research Tool for Neurological Disorders
Gabriele Bonaventura, Rosario Iemmolo, Giuseppe Antonino Attaguile, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4596-4596
Open Access | Times Cited: 28
Lysosomal ceramides regulate cathepsin B-mediated processing of saposin C and glucocerebrosidase activity
Myung Jong Kim, Hyunkyung Jeong, Dimitri Krainc
Human Molecular Genetics (2022) Vol. 31, Iss. 14, pp. 2424-2437
Open Access | Times Cited: 22
Lysophosphatidylcholine promoting α-Synuclein aggregation in Parkinson’s disease: disrupting GCase glycosylation and lysosomal α-Synuclein degradation
Chunyan Mu, Kaiquan Shao, Mingyu Su, et al.
npj Parkinson s Disease (2025) Vol. 11, Iss. 1
Open Access
CoPPIs algorithm: a tool to unravel protein cooperative strategies in pathophysiological conditions
Andrea Lomagno, Ishak Yusuf, Gabriele Tosadori, et al.
Briefings in Bioinformatics (2025) Vol. 26, Iss. 2
Open Access
Sphingolipidoses: expanding the spectrum of α-synucleinopathies
Daniel Erskine, Agnieszka K. Bronowska, Tiago F. Outeiro, et al.
Journal of Neural Transmission (2025)
Open Access
Elevated Glucosylsphingosine in Gaucher Disease induced Pluripotent Stem Cell Neurons Deregulates Lysosomal Compartment through Mammalian Target of Rapamycin Complex 1
Manasa P. Srikanth, Jace W. Jones, Maureen A. Kane, et al.
Stem Cells Translational Medicine (2021) Vol. 10, Iss. 7, pp. 1081-1094
Open Access | Times Cited: 24
Exploring the link between GBA1 mutations and Dementia with Lewy bodies, A mini-review
Sinead Gaubert, Claire Hourrègue, François Mouton‐Liger, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 141, pp. 104856-104856
Open Access | Times Cited: 16
Acid ceramidase involved in pathogenic cascade leading to accumulation of α-synuclein in iPSC model of GBA1-associated Parkinson’s disease
Manoj Kumar, Manasa P. Srikanth, Michela Deleidi, et al.
Human Molecular Genetics (2023) Vol. 32, Iss. 11, pp. 1888-1900
Open Access | Times Cited: 10
Parkinsonisms and Glucocerebrosidase Deficiency: A Comprehensive Review for Molecular and Cellular Mechanism of Glucocerebrosidase Deficiency
Emilia Gatto, Gustavo Da Prat, José Luis Etcheverry, et al.
Brain Sciences (2019) Vol. 9, Iss. 2, pp. 30-30
Open Access | Times Cited: 23
Elusive Roles of the Different Ceramidases in Human Health, Pathophysiology, and Tissue Regeneration
Carolina Duarte, Juliet Akkaoui, Chiaki Yamada, et al.
Cells (2020) Vol. 9, Iss. 6, pp. 1379-1379
Open Access | Times Cited: 23
Finding pathogenic commonalities between Niemann-Pick type C and other lysosomal storage disorders: Opportunities for shared therapeutic interventions
Maria Yanez, Tamara Marín, Elisa Balboa, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2020) Vol. 1866, Iss. 10, pp. 165875-165875
Closed Access | Times Cited: 21
Lysosomal enzyme activities as possible CSF biomarkers of synucleinopathies
Silvia Paciotti, Leonardo Gatticchi, Tommaso Beccari, et al.
Clinica Chimica Acta (2019) Vol. 495, pp. 13-24
Closed Access | Times Cited: 20
Enhancing the Activity of Glucocerebrosidase as a Treatment for Parkinson Disease
Elisa Menozzi, Anthony H.V. Schapira
CNS Drugs (2020) Vol. 34, Iss. 9, pp. 915-923
Closed Access | Times Cited: 19
Development of Midbrain Dopaminergic Neurons and the Advantage of Using hiPSCs as a Model System to Study Parkinson’s Disease
Jennifer Sally Samson, Anuradha Ramesh, Venkatachalam Deepa Parvathi
Neuroscience (2024) Vol. 546, pp. 1-19
Closed Access | Times Cited: 2
Proteomics and lipidomic analysis reveal dysregulated pathways associated with loss of sacsin
Daniele Galatolo, Silvia Rocchiccioli, Nicoletta Di Giorgi, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 2
The role of dopamine in the pathogenesis of GBA1-linked Parkinson's disease
Lena F. Burbulla, Dimitri Krainc
Neurobiology of Disease (2019) Vol. 132, pp. 104545-104545
Open Access | Times Cited: 19
GBA1 mutations: Prospects for exosomal biomarkers in α-synuclein pathologies
Parker H. Johnson, Neal J. Weinreb, James C. Cloyd, et al.
Molecular Genetics and Metabolism (2019) Vol. 129, Iss. 2, pp. 35-46
Open Access | Times Cited: 18
Patient-Derived Induced Pluripotent Stem Cell-Based Models in Parkinson’s Disease for Drug Identification
Georgia Kouroupi, Nasia Antoniou, Kanella Prodromidou, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 19, pp. 7113-7113
Open Access | Times Cited: 17
Inborn errors of metabolism: Lessons from iPSC models
Rubén Escribá, Raquel Ferrer‐Lorente, Ángel Raya
Reviews in Endocrine and Metabolic Disorders (2021) Vol. 22, Iss. 4, pp. 1189-1200
Open Access | Times Cited: 15
Ups and downs of lysosomal pH: conflicting roles of LAMP proteins?
Jonathan Handy, Gustavo C. MacIntosh, Andreas Jenny
Autophagy (2023) Vol. 20, Iss. 2, pp. 437-440
Closed Access | Times Cited: 4

Scroll to top